SEC Form 4 · accession 0001209191-16-128036
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mauro Ferrari
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 15, 2016 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 13, 2016 | A | 8,517 | $0.00 | A | 12,768 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Ferrari has historically declined to accept cash or equity compensation for his service based on the previous policies of his employer. During 2016, the policies of his employer changed to allow certain other compensation. This award represents compensation for his services performed during fiscal 2016.